PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
METiS TechBio, the World's First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, "The SpaceX of Pharmaceuticals" Ushers in a New Era of Biopharmaceuticals
HONG KONG , May 14, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a tech-bio company focused on AI-powered nanodelivery innovation, today successfully listed on the Hong Kong Stock Exchange (HKEX), becoming ...
2026-05-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Watson-Marlow Showcases Advanced Fluid Path Solutions for Slurry Transfer in Battery Production at China International Battery Fair 2026
SHENZHEN, China , May 14, 2026 /PRNewswire/ -- Watson-Marlow Fluid Technology Solutions, a world leader in manufacturing peristaltic pumps and associated fluid path technologies, will showcase its latest ...
2026-05-14T    Biotechnology   Chemical   Environmental Products & Services   Health Care/Hospital 
Elabscience® Launches Self-Developed PolyHRP-Streptavidin Conjugate for Low-Abundance Biomarker Detection in ELISA
HOUSTON , May 14, 2026 /PRNewswire/ -- Elabscience ® Bionovation Inc. ("Elabscience ® " or "the Company") today announced the launch of its self-developed PolyHRP-Streptavidin ...
2026-05-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialized solutions for payload-linkers. This cutting-edge ...
2026-05-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
LONDON , May 13, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's leading pathology ...
2026-05-13T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical Equipment 
WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index
SHANGHAI , May 13, 2026 /PRNewswire/ --  WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that, in recognition of its continued ...
2026-05-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody
CHENGDU, China , May 12, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical ...
2026-05-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class
New kit offers researchers and development teams a meaningful advance in expression speed and output ...
2026-05-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Porton Advanced and Dark Horse Consulting Group Announce Memorandum of Understanding Providing A Streamlined Path to Conducting IITs in China
CRANBURY, N.J. and SUZHOU, China , May 12, 2026 /PRNewswire/ -- Porton Advanced, a premier contract development and manufacturing organization (CDMO) specializing in Advanced Therapy Medicinal Products ...
2026-05-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine
Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. ...
2026-05-12T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.